$0.01 EPS Expected for Alamos Gold Inc. (AGI); Shire Plc Ads (SHPG) Shorts Increased By 38.7%

February 15, 2018 - By Michael Collier

Shire Plc Ads (NASDAQ:SHPG) had an increase of 38.7% in short interest. SHPG’s SI was 3.85 million shares in February as released by FINRA. Its up 38.7% from 2.78M shares previously. With 1.39 million avg volume, 3 days are for Shire Plc Ads (NASDAQ:SHPG)’s short sellers to cover SHPG’s short positions. The SI to Shire Plc Ads’s float is 1.29%. The stock increased 0.14% or $0.19 during the last trading session, reaching $132.86. About 2.04M shares traded or 53.86% up from the average. Shire plc (NASDAQ:SHPG) has risen 4.69% since February 15, 2017 and is uptrending. It has underperformed by 12.01% the S&P500.

Analysts expect Alamos Gold Inc. (TSE:AGI) to report $0.01 EPS on February, 22.They anticipate $0.05 EPS change or 125.00% from last quarter’s $-0.04 EPS. T_AGI’s profit would be $3.89 million giving it 177.50 P/E if the $0.01 EPS is correct. After having $0.06 EPS previously, Alamos Gold Inc.’s analysts see -83.33% EPS growth. The stock increased 4.57% or $0.31 during the last trading session, reaching $7.1. About 1.00M shares traded. Alamos Gold Inc. (TSE:AGI) has 0.00% since February 15, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 25 analysts covering Shire plc (ADR) (NASDAQ:SHPG), 21 have Buy rating, 0 Sell and 4 Hold. Therefore 84% are positive. Shire plc (ADR) had 66 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Hold” rating by HSBC given on Thursday, July 6. The firm has “Buy” rating given on Tuesday, November 14 by Liberum Capital. The firm has “Buy” rating given on Monday, February 5 by RBC Capital Markets. The rating was maintained by RBC Capital Markets on Monday, September 28 with “Sector Perform”. The firm has “Hold” rating by HSBC given on Wednesday, September 30. The stock of Shire plc (NASDAQ:SHPG) has “Buy” rating given on Monday, July 10 by RBC Capital Markets. The stock of Shire plc (NASDAQ:SHPG) has “Buy” rating given on Tuesday, September 5 by Jefferies. The stock of Shire plc (NASDAQ:SHPG) has “Overweight” rating given on Friday, June 3 by Morgan Stanley. The stock of Shire plc (NASDAQ:SHPG) has “Buy” rating given on Wednesday, October 18 by FBR Capital. On Tuesday, November 3 the stock rating was upgraded by HSBC to “Buy”.

Shire plc, a biotechnology company, focused on serving people with rare diseases and other specialized conditions worldwide. The company has market cap of $37.70 billion. The firm offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology. It has a 25.11 P/E ratio. The Company’s marketed products include ADVATE and ADYNOVATE/ADYNOVI for hemophilia A; RIXUBIS to treat hemophilia B; VONVENDI for the treatment of von willebrand Disease; FEIBA to treat hemophilia A and B patients with inhibitors; CINRYZE and FIRAZYR for hereditary angioedema; ELAPRASE to treat hunter syndrome; REPLAGAL for Fabry disease; and VPRIV to treat type 1 Gaucher disease.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts